Compare GHM & ABSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GHM | ABSI |
|---|---|---|
| Founded | 1936 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 997.8M |
| IPO Year | 1994 | 2021 |
| Metric | GHM | ABSI |
|---|---|---|
| Price | $87.90 | $8.21 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 4 |
| Target Price | ★ $73.33 | $6.96 |
| AVG Volume (30 Days) | 141.5K | ★ 2.7M |
| Earning Date | 06-08-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 0.90 | ★ 10.64 |
| EPS | ★ 0.33 | N/A |
| Revenue | ★ $245,293,000.00 | $4,534,000.00 |
| Revenue This Year | $14.54 | $215.96 |
| Revenue Next Year | $18.23 | $319.10 |
| P/E Ratio | $265.09 | ★ N/A |
| Revenue Growth | ★ 16.86 | N/A |
| 52 Week Low | $48.47 | $2.24 |
| 52 Week High | $125.82 | $12.06 |
| Indicator | GHM | ABSI |
|---|---|---|
| Relative Strength Index (RSI) | 36.30 | 40.77 |
| Support Level | $75.91 | $6.69 |
| Resistance Level | $89.65 | $10.03 |
| Average True Range (ATR) | 4.20 | 0.54 |
| MACD | -0.53 | -0.12 |
| Stochastic Oscillator | 16.94 | 0.81 |
Graham Corp designs and manufactures mission-critical fluid, power, heat transfer, vacuum, and mixing technologies for the Defense, Energy & Process, and Space industries. In Defense, its equipment is used in nuclear and non-nuclear propulsion, power, fluid transfer, thermal management, and mixing systems. In Energy & Process industries, it supplies equipment for vacuum, heat transfer, mixing, and fluid transfer applications used in oil refining, chemical facilities, fertilizers, ethylene, methanol, energetics, food & beverage, medical, and alternative energy applications such as hydrogen and geothermal processes. In the Space industry, its equipment is used in propulsion, power, thermal management, mixing, and life support systems. It operates in the United States and other countries.
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process. Its lead product candidate, ABS-201, is an anti-prolactin receptor (PRLR) antibody engineered with an extended half-life to support a patient-friendly dosing interval.